Aew Capital Management L P acquired a new stake in Global Medical REIT Inc. (NYSE:GMRE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 29,820 shares of the company's stock, valued at approximately $230,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Creative Planning boosted its stake in shares of Global Medical REIT by 13.3% in the 3rd quarter. Creative Planning now owns 22,980 shares of the company's stock valued at $228,000 after purchasing an additional 2,702 shares in the last quarter. International Assets Investment Management LLC lifted its stake in Global Medical REIT by 900.1% in the 3rd quarter. International Assets Investment Management LLC now owns 21,313 shares of the company's stock valued at $2,151,000 after purchasing an additional 19,182 shares during the last quarter. First Trust Direct Indexing L.P. boosted its position in Global Medical REIT by 25.6% in the third quarter. First Trust Direct Indexing L.P. now owns 20,432 shares of the company's stock valued at $202,000 after buying an additional 4,164 shares in the last quarter. M&G PLC bought a new stake in shares of Global Medical REIT during the third quarter worth $193,000. Finally, State of New Jersey Common Pension Fund D increased its holdings in shares of Global Medical REIT by 8.0% during the third quarter. State of New Jersey Common Pension Fund D now owns 637,751 shares of the company's stock worth $6,320,000 after buying an additional 47,500 shares in the last quarter. Institutional investors own 57.52% of the company's stock.
Global Medical REIT Price Performance
Shares of NYSE GMRE traded down $0.09 during mid-day trading on Wednesday, hitting $8.87. 544,641 shares of the stock traded hands, compared to its average volume of 416,864. The company has a market cap of $592.61 million, a PE ratio of -443.33, a price-to-earnings-growth ratio of 1.43 and a beta of 1.24. Global Medical REIT Inc. has a twelve month low of $7.33 and a twelve month high of $10.46. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28. The firm has a 50 day simple moving average of $8.01 and a two-hundred day simple moving average of $8.74.
Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.01 by $0.21. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The firm had revenue of $35.16 million for the quarter, compared to analyst estimates of $34.87 million. As a group, equities research analysts forecast that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.
Global Medical REIT Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 9th. Shareholders of record on Friday, March 21st will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 9.47%. The ex-dividend date of this dividend is Friday, March 21st. Global Medical REIT's payout ratio is 8,400.00%.
Global Medical REIT Company Profile
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Featured Articles
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
